We are analyzing https://link.springer.com/article/10.1186/s13287-021-02407-5.

Title:
hPMSCs inhibit the expression of PD-1 in CD4+IL-10+ T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-κB signaling pathway | Stem Cell Research & Therapy
Description:
Background The activation of T cells and imbalanced redox metabolism enhances the development of graft-versus-host disease (GVHD). Human placenta-derived mesenchymal stromal cells (hPMSCs) can improve GVHD through regulating T cell responses. However, whether hPMSCs balance the redox metabolism of CD4+IL-10+ T cells and liver tissue and alleviate GVHD remains unclear. This study aimed to investigate the effect of hPMSC-mediated treatment of GVHD associated with CD4+IL-10+ T cell generation via control of redox metabolism and PD-1 expression and whether the Nrf2 and NF-κB signaling pathways were both involved in the process. Methods A GVHD mouse model was induced using 6–8-week-old C57BL/6 and Balb/c mice, which were treated with hPMSCs. In order to observe whether hPMSCs affect the generation of CD4+IL-10+ T cells via control of redox metabolism and PD-1 expression, a CD4+IL-10+ T cell culture system was induced using human naive CD4+ T cells. The percentage of CD4+IL-10+ T cells and their PD-1 expression levels were determined in vivo and in vitro using flow cytometry, and Nrf2, HO-1, NQO1, GCLC, GCLM, and NF-κB levels were determined by western blotting, qRT-PCR, and immunofluorescence, respectively. Hematoxylin-eosin, Masson’s trichrome, and periodic acid-Schiff staining methods were employed to analyze the changes in hepatic tissue. Results A decreased activity of superoxide dismutase (SOD) and a proportion of CD4+IL-10+ T cells with increased PD-1 expression were observed in GVHD patients and the mouse model. Treatment with hPMSCs increased SOD activity and GCL and GSH levels in the GVHD mouse model. The percentage of CD4+IL-10+ T cells with decreased PD-1 expression, as well as Nrf2, HO-1, NQO1, GCLC, and GCLM levels, both in the GVHD mouse model and in the process of CD4+IL-10+ T cell generation, were also increased, but NF-κB phosphorylation and nuclear translocation were inhibited after treatment with hPMSCs, which was accompanied by improvement of hepatic histopathological changes. Conclusions The findings suggested that hPMSC-mediated redox metabolism balance and decreased PD-1 expression in CD4+IL-10+ T cells were achieved by controlling the crosstalk between Nrf2 and NF-κB, which further provided evidence for the application of hPMSC-mediated treatment of GVHD.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cells, hpmscs, cdil, gvhd, nrf, expression, levels, liver, nfκb, cell, fig, article, group, mice, pubmed, mouse, nqo, gclc, gclm, spleen, model, results, increased, treatment, google, scholar, redox, compared, damage, decreased, activation, metabolism, china, cas, naive, gsh, apoptosis, mononuclear, significantly, patients, sod, inhibit, signaling, zhang, human, showed, differentiation, pbs, inflammatory, obtained,

Topics {✒️}

acute graft-versus-host disease experimental graft-versus-host disease graft-versus-host disease mesenchymal stem cells anti-mouse cd3-percp-cy5 nf-kappab/p65 antagonizes nrf2 d-galactose-induced oxidative damage goat anti-mouse igg anti-human cd28 mab mouse spermatocyte-derived cells nuclear factor kappa dissecting molecular cross-talk anti-human il-10-fitc periodic acid-schiff anti-human cd4-apc anti-human pd-1-pe healthy-term pregnant women goat anti-rabbit central blood bank article download pdf fluorescently labeled antibodies anti-mouse il-10-fitc p-i-κb increased significantly nf-κb signaling pathways programmed cell death nf-kappab response pathways nf-κb signaling pathway nf-kappab pathway dependent anti-mouse cd4-apc gvhd cell therapy anti-mouse pd-1-pe ros-mediated lipid peroxidation anti-human cd3ε male c57bl/6j mice keratinocyte growth factor p-i-κb compared low-glucose dmem supplemented anti-inflammatory cytokine expression inflammation-related diseases privacy choices/manage cookies full access modulating th17/tr1 balance animal ethics committee green fluorescent protein key transcription factor nf-κb increased compared p-i-κb levels inflammatory bowel disease programmed death-1 inhibiting nf-κb levels

Schema {🗺️}

WebPage:
      mainEntity:
         headline:hPMSCs inhibit the expression of PD-1 in CD4+IL-10+ T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-κB signaling pathway
         description:The activation of T cells and imbalanced redox metabolism enhances the development of graft-versus-host disease (GVHD). Human placenta-derived mesenchymal stromal cells (hPMSCs) can improve GVHD through regulating T cell responses. However, whether hPMSCs balance the redox metabolism of CD4+IL-10+ T cells and liver tissue and alleviate GVHD remains unclear. This study aimed to investigate the effect of hPMSC-mediated treatment of GVHD associated with CD4+IL-10+ T cell generation via control of redox metabolism and PD-1 expression and whether the Nrf2 and NF-κB signaling pathways were both involved in the process. A GVHD mouse model was induced using 6–8-week-old C57BL/6 and Balb/c mice, which were treated with hPMSCs. In order to observe whether hPMSCs affect the generation of CD4+IL-10+ T cells via control of redox metabolism and PD-1 expression, a CD4+IL-10+ T cell culture system was induced using human naive CD4+ T cells. The percentage of CD4+IL-10+ T cells and their PD-1 expression levels were determined in vivo and in vitro using flow cytometry, and Nrf2, HO-1, NQO1, GCLC, GCLM, and NF-κB levels were determined by western blotting, qRT-PCR, and immunofluorescence, respectively. Hematoxylin-eosin, Masson’s trichrome, and periodic acid-Schiff staining methods were employed to analyze the changes in hepatic tissue. A decreased activity of superoxide dismutase (SOD) and a proportion of CD4+IL-10+ T cells with increased PD-1 expression were observed in GVHD patients and the mouse model. Treatment with hPMSCs increased SOD activity and GCL and GSH levels in the GVHD mouse model. The percentage of CD4+IL-10+ T cells with decreased PD-1 expression, as well as Nrf2, HO-1, NQO1, GCLC, and GCLM levels, both in the GVHD mouse model and in the process of CD4+IL-10+ T cell generation, were also increased, but NF-κB phosphorylation and nuclear translocation were inhibited after treatment with hPMSCs, which was accompanied by improvement of hepatic histopathological changes. The findings suggested that hPMSC-mediated redox metabolism balance and decreased PD-1 expression in CD4+IL-10+ T cells were achieved by controlling the crosstalk between Nrf2 and NF-κB, which further provided evidence for the application of hPMSC-mediated treatment of GVHD.
         datePublished:2021-06-29T00:00:00Z
         dateModified:2021-06-29T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13287-021-02407-5
         keywords:
            Human placenta-derived mesenchymal stromal cells
            Programmed death-1
            CD4+IL-10+ T cells
            Nuclear factor-E2-related factor 2
            Nuclear factor kappa-B
            Graft-versus-host disease
            Stem Cells
            Cell Biology
            Regenerative Medicine/Tissue Engineering
            Biomedical Engineering and Bioengineering
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig8_HTML.png
         isPartOf:
            name:Stem Cell Research & Therapy
            issn:
               1757-6512
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Aiping Zhang
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jiashen Zhang
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaohua Li
               affiliation:
                     name:Yantai Central Blood Station
                     address:
                        name:Department of Component, Yantai Central Blood Station, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hengchao Zhang
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yanlian Xiong
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Anatomy, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhuoya Wang
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nannan Zhao
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feifei Wang
               affiliation:
                     name:Yantai Affiliated Hospital of Binzhou Medical University
                     address:
                        name:Department of Anesthesiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Xiying Luan
               affiliation:
                     name:Binzhou Medical University
                     address:
                        name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:hPMSCs inhibit the expression of PD-1 in CD4+IL-10+ T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-κB signaling pathway
      description:The activation of T cells and imbalanced redox metabolism enhances the development of graft-versus-host disease (GVHD). Human placenta-derived mesenchymal stromal cells (hPMSCs) can improve GVHD through regulating T cell responses. However, whether hPMSCs balance the redox metabolism of CD4+IL-10+ T cells and liver tissue and alleviate GVHD remains unclear. This study aimed to investigate the effect of hPMSC-mediated treatment of GVHD associated with CD4+IL-10+ T cell generation via control of redox metabolism and PD-1 expression and whether the Nrf2 and NF-κB signaling pathways were both involved in the process. A GVHD mouse model was induced using 6–8-week-old C57BL/6 and Balb/c mice, which were treated with hPMSCs. In order to observe whether hPMSCs affect the generation of CD4+IL-10+ T cells via control of redox metabolism and PD-1 expression, a CD4+IL-10+ T cell culture system was induced using human naive CD4+ T cells. The percentage of CD4+IL-10+ T cells and their PD-1 expression levels were determined in vivo and in vitro using flow cytometry, and Nrf2, HO-1, NQO1, GCLC, GCLM, and NF-κB levels were determined by western blotting, qRT-PCR, and immunofluorescence, respectively. Hematoxylin-eosin, Masson’s trichrome, and periodic acid-Schiff staining methods were employed to analyze the changes in hepatic tissue. A decreased activity of superoxide dismutase (SOD) and a proportion of CD4+IL-10+ T cells with increased PD-1 expression were observed in GVHD patients and the mouse model. Treatment with hPMSCs increased SOD activity and GCL and GSH levels in the GVHD mouse model. The percentage of CD4+IL-10+ T cells with decreased PD-1 expression, as well as Nrf2, HO-1, NQO1, GCLC, and GCLM levels, both in the GVHD mouse model and in the process of CD4+IL-10+ T cell generation, were also increased, but NF-κB phosphorylation and nuclear translocation were inhibited after treatment with hPMSCs, which was accompanied by improvement of hepatic histopathological changes. The findings suggested that hPMSC-mediated redox metabolism balance and decreased PD-1 expression in CD4+IL-10+ T cells were achieved by controlling the crosstalk between Nrf2 and NF-κB, which further provided evidence for the application of hPMSC-mediated treatment of GVHD.
      datePublished:2021-06-29T00:00:00Z
      dateModified:2021-06-29T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13287-021-02407-5
      keywords:
         Human placenta-derived mesenchymal stromal cells
         Programmed death-1
         CD4+IL-10+ T cells
         Nuclear factor-E2-related factor 2
         Nuclear factor kappa-B
         Graft-versus-host disease
         Stem Cells
         Cell Biology
         Regenerative Medicine/Tissue Engineering
         Biomedical Engineering and Bioengineering
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13287-021-02407-5/MediaObjects/13287_2021_2407_Fig8_HTML.png
      isPartOf:
         name:Stem Cell Research & Therapy
         issn:
            1757-6512
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Aiping Zhang
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jiashen Zhang
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaohua Li
            affiliation:
                  name:Yantai Central Blood Station
                  address:
                     name:Department of Component, Yantai Central Blood Station, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hengchao Zhang
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yanlian Xiong
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Anatomy, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhuoya Wang
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nannan Zhao
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feifei Wang
            affiliation:
                  name:Yantai Affiliated Hospital of Binzhou Medical University
                  address:
                     name:Department of Anesthesiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Xiying Luan
            affiliation:
                  name:Binzhou Medical University
                  address:
                     name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Stem Cell Research & Therapy
      issn:
         1757-6512
      volumeNumber:12
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Yantai Central Blood Station
      address:
         name:Department of Component, Yantai Central Blood Station, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Anatomy, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Yantai Affiliated Hospital of Binzhou Medical University
      address:
         name:Department of Anesthesiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
      name:Binzhou Medical University
      address:
         name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Aiping Zhang
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Jiashen Zhang
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xiaohua Li
      affiliation:
            name:Yantai Central Blood Station
            address:
               name:Department of Component, Yantai Central Blood Station, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Hengchao Zhang
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Yanlian Xiong
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Anatomy, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Zhuoya Wang
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Nannan Zhao
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Feifei Wang
      affiliation:
            name:Yantai Affiliated Hospital of Binzhou Medical University
            address:
               name:Department of Anesthesiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Xiying Luan
      affiliation:
            name:Binzhou Medical University
            address:
               name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Component, Yantai Central Blood Station, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Anatomy, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Anesthesiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, People’s Republic of China
      name:Department of Immunology, Binzhou Medical University, Yantai, People’s Republic of China

External Links {🔗}(158)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.42s.

LINK . SPRINGER . COM {}